Par profesionales de la salud

Relationship Between Sarcopenia and Frailty in the Toledo Study of Healthy Aging: A Population Based Cross-Sectional Study

B. Davies, F. García, I. Ara, et al.

J Am Med Dir Assoc. 2018;19(4):282-286

Frailty and sarcopenia are distinct but related conditions.

Sarcopenia is not a useful clinical biomarker of frailty, but its absence might be useful to exclude frailty.

 

 

Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults - The PROVIDE study

S. Verlaan, A.B. Maier, J.M. Bauer, et al.

Clin Nutr. 2018;37(2):551-557

This study wants to test if baseline serum 25-hydroxyvitamin D (25(OH)D) concentrations and dietary protein intake influenced changes in muscle mass and function in older adults who received nutritional intervention.

 

 

Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures

C.D. Chang, J.S. Wu, J.N. Mhuircheartaigh, et al.

Skeletal Radiol. 2018;47(6):771-777

In proximal femur fractures, elderly patients with sarcopenia are more likely to have prolonged hospitalization following surgery and require more blood transfusion volume during the perioperative period.

 

 

Effect of Protein Intake on Lean Body Mass in Functionally Limited Older Men

S. Bhasin, C.M. Apovian, T.G. Travison, et al.

JAMA Intern Med. 2018;178(4):530-541

This study aimed at investigating whether increasing protein intake to 1.3 g/kg/d in older adults with physical function limitations compared with usual protein intake within the RDA (0.8 g/kg/d) improves lean body mass (LBM), muscle performance, physical function, fatigue, and well-being and augments LBM response to a muscle anabolic drug.

 

 

Maintenance of Physical Function 1 Year After Exercise Intervention in At-Risk Older Adults: Follow-up From the LIFE Study

R.M. Henderson, M.E. Miller, R.A. Fielding, et al.

J Gerontol A Biol Sci Med Sci. 2018;73(5):688-694

Structured physical activity interventions delay the onset of disability for at-risk older adults. However, it is not known if at-risk older adults continue to participate in physical activity or maintain mobility benefits after cessation of structured intervention.

 

 

Impact of Sarcopenia on One-Year Mortality among Older Hospitalized Patients with Impaired Mobility

M. Pourhassan, K. Norman, M.J. Müller, et al.

J Frailty Aging. 2018;7(1):40-46

The aim of the present study was to investigate the associations between sarcopenia and 1-year mortality in a prospectively recruited sample of geriatric inpatients with different mobility and dependency status.

 

 

Pages